The New Obesity Management Landscape: Beyond the scale

GLP-1 and dual-incretin therapies now produce weight loss that is close to what was possible only with surgery. Clinicians face new questions; we have moved on from do they work to how do we support our patients long term with them? How much of the weight lost is lean mass? Which patients develop nutrient deficiencies, disordered eating, or hair and facial changes on treatment? When are non-incretin agents or combination regimens appropriate? What happens when therapy is interrupted for surgery, pregnancy, or supply problems? And how do we reach patients with rare genetic obesity, or those who face economic and structural barriers?

This one-day, accredited program addresses those questions through keynote, lecture, fireside-chat, and integrated Q&A formats. Faculty will present current evidence on pathophysiology, pharmacotherapy, nutrition, exercise, sleep, procedural options, and payer navigation.

Registration

In-Person and Virtual Attendance Fees

• $150 Physicians
• $75 Nurses and Allied Health Professionals
• $50 Fellows/Medical Students

Accepted Payment Methods: Credit Card and E-Check (ACH) or UC Interdepartmental/campus Recharge.

UC Recharge Payment Information
Registration payment can be submitted via the Interdepartmental or Intercampus recharge system.
For more details, please refer to document here: Recharge Information

Refunds
Cancellations must be received via email by Sunday, April 11, 2027, and will be subject to a $25 processing fee. No refunds will be granted after that date. David Geffen School of Medicine at UCLA reserves the right to cancel or postpone this course if necessary; in the event of cancellation, course fees will be fully refunded to the original form of payment. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Course Recording
All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the course.
The recorded sessions are not approved for Continuing Education (CE) credit.

Questions
If you have questions about enrollment, please email or call the team.

Target Audience
Specialties - Bariatric Surgery, Dermatology, Endocrinology, Diabetes and Metabolism, Family Medicine, Gastroenterology, Internal Medicine, Medical Genetics and Genomics, Obstetrics and Gynecology, Preventive Medicine, Psychiatry and Neurology, Sleep Medicine, Surgery

Professions - Advanced Practice Nurse, Dietitian/Nutritionist, Exercise Physiologist, Fellow/Resident, Nurse, Pharmacist, Physician, Physician Assistant, Psychologist

Learning Objectives

At the conclusion of this activity, learners will be able to:

1. Evaluate the evidence on lean mass loss during incretin therapy and apply strategies to monitor and preserve muscle and physical function.
2. Compare GLP-1, dual-, and multi-agonist therapies with non-incretin agents, and select, sequence, or combine medications based on patient characteristics.
3. Design nutrition and exercise plans that support high-quality weight loss and reduce the risk of nutrient deficiencies.
4. Recognize and manage obstructive sleep apnea and circadian factors in patients receiving weight-management therapy.
5. Identify patients who warrant evaluation for monogenic or syndromic obesity or who carry eating-disorder risk, and apply safety frameworks when prescribing.
6. Plan for incretin interruptions around surgery, pregnancy, and supply disruptions, and manage hair loss and facial volume loss during rapid weight loss.
7. Determine when to refer for endobariatric procedures or bariatric surgery, and how to combine surgery with post-operative pharmacotherapy.
8. Apply strategies to address cost, food access, weight bias, and payer requirements (formularies, prior authorization) so more patients can start and stay on treatment.

Accreditation

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.